The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for lurbinectedin (Specialised Therapeutics Pharma Pty Ltd)
Active ingredients
lurbinectedin
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
IV injection/powder for solution;
Indication
For the treatment of small cell lung cancer
Therapeutic area
Respiratory